For example, Theodoraki et al. (2018) showed that in HNSCC patients, higher plasma levels of exosome PD-L1 were associated with stronger inhibition of CD8 effector T cell activation. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.